Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vertex Spots Potential Bargain Of $60m Entry Into Complement Regulation
Cash-Strapped Catalyst Bio Forced Into Quick Sale
May 24 2022
•
By
Andrew McConaghie
Rights to the assets were handed back by Biogen in March, and have now been acquired in full by Vertex. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business